Dashboard
Manage Tickers

JNJ JOHNSON & JOHNSON

NYSE jnj.com


$ 190.70 $ 0.18 (0.09 %)    

Monday, 13-Oct-2025 19:59:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.81 $ 12.51 (2.12 %)
DIA $ 460.92 $ 5.81 (1.28 %)
SPY $ 662.71 $ 10.02 (1.53 %)
TLT $ 90.54 $ -0.05 (-0.06 %)
GLD $ 379.71 $ 8.97 (2.43 %)
$ 190.9
$ 189.33
$ 190.00 x 5
$ 190.81 x 1
$ 189.28 - $ 191.30
$ 137.37 - $ 192.10
7,979,476
na
459.75B
$ 0.34
$ 20.29
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2025 06-29-2025 10-Q
2 04-23-2025 03-30-2025 10-Q
3 02-13-2025 12-29-2024 10-K
4 10-23-2024 09-29-2024 10-Q
5 07-25-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-16-2024 12-31-2023 10-K
8 10-27-2023 10-01-2023 10-Q
9 10-27-2023 10-01-2023 10-Q
10 07-31-2023 07-02-2023 10-Q
11 04-28-2023 04-02-2023 10-Q
12 02-16-2023 01-01-2023 10-K
13 10-27-2022 10-02-2022 10-Q
14 07-29-2022 07-03-2022 10-Q
15 04-29-2022 04-03-2022 10-Q
16 02-17-2022 01-02-2022 10-K
17 10-29-2021 10-03-2021 10-Q
18 07-29-2021 07-04-2021 10-Q
19 04-30-2021 04-04-2021 10-Q
20 02-22-2021 01-03-2021 10-K
21 10-23-2020 09-27-2020 10-Q
22 07-24-2020 06-28-2020 10-Q
23 04-29-2020 03-29-2020 10-Q
24 02-18-2020 12-29-2019 10-K
25 10-28-2019 09-29-2019 10-Q
26 07-29-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-20-2019 12-30-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-02-2018 07-01-2018 10-Q
31 05-01-2018 04-01-2018 10-Q
32 02-21-2018 12-31-2017 10-K
33 11-02-2017 10-01-2017 10-Q
34 08-03-2017 07-02-2017 10-Q
35 05-08-2017 04-02-2017 10-Q
36 02-27-2017 01-01-2017 10-K
37 11-04-2016 10-02-2016 10-Q
38 08-04-2016 07-03-2016 10-Q
39 05-10-2016 04-03-2016 10-Q
40 02-24-2016 01-03-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

goldman-sachs-jpmorgan-chase-and-3-stocks-to-watch-heading-into-tuesday
Goldman Sachs, JPMorgan Chase And 3 Stocks...
10/14/2025 06:17:11

US stock futures lower, focus on Goldman Sachs, JPMorgan, Polaris, Johnson & Johnson, and Citigroup earnings.

atai-life-sciences-remains-undervalued-analyst-initiates-with-around-125-stock-upside
Atai Life Sciences Remains Undervalued, An...
10/13/2025 18:21:17

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion s...

johnson--johnson-q3-preview-with-stock-near-all-time-highs-heres-what-to-watch
Johnson & Johnson Q3 Preview: With Stock N...
10/13/2025 16:27:44

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

fda-adds-new-warning-for-johnson--johnsons-cancer-cell-therapy
FDA Adds New Warning For Johnson & Johnson...
10/13/2025 14:30:41

FDA updates Johnson & Johnson's Carvykti label to warn of rare immune-related enterocolitis while reaffirming the thera...

a-peek-at-johnson--johnsons-future-earnings
A Peek at Johnson & Johnson's Future Earnings
10/13/2025 14:00:50

retail-investors-top-stocks-with-earnings-this-week-fastenal-asml-tsmc-and-more
Retail Investors' Top Stocks With Earnings...
10/13/2025 12:01:42

Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this w...

fda-approves-labeling-changes-including-boxed-warning-for-immune-effector-cell-associated-enterocolitis-after-treatment-with-ciltacabtagene-autoleucel--determined-overall-benefit-of-carvykti-continues-to-outweigh-potential-risks-for-approved-use
FDA Approves Labeling Changes Including Bo...
10/10/2025 21:32:27

https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-labeling-changes-include-boxed-warning-...

johnson--johnson-warns-shareholders-to-reject-mini-tender-offer-by-tutanota-to-purchase-up-to-500k-shares-of-the-companys-common-stock-at-a-price-of-14500share-in-cash
Johnson & Johnson Warns Shareholders To Re...
10/10/2025 20:22:57

Johnson & Johnson (NYSE:JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LL...

morgan-stanley-maintains-equal-weight-on-johnson--johnson-raises-price-target-to-178
Morgan Stanley Maintains Equal-Weight on J...
10/10/2025 17:38:25

Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Equal-Weight and raises the price tar...

johnson--johnson-in-talks-to-acquire-protagonist-therapeutics-report
Johnson & Johnson In Talks To Acquire Prot...
10/10/2025 17:06:05

Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug po...

Core News & Articles
'Johnson & Johnson In Talks To Buy Protago...
10/10/2025 15:15:04

https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d

johnson--johnson-to-present-17-abstracts-featuring-new-clinical-and-real-world-data-at-annual-ecnp-congress
Johnson & Johnson To Present 17 Abstracts ...
10/10/2025 11:33:07

17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressiv...

johnson--johnson-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts
Johnson & Johnson Gears Up For Q3 Print; H...
10/10/2025 06:42:46

what-analysts-are-saying-about-johnson--johnson-stock
What Analysts Are Saying About Johnson & J...
10/09/2025 20:01:18

goldman-sachs-maintains-buy-on-johnson--johnson-raises-price-target-to-212
Goldman Sachs Maintains Buy on Johnson & J...
10/09/2025 17:45:16

Goldman Sachs analyst Asad Haider maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $1...

fda-expands-johnson--johnson-ulcerative-colitis-drug-approval-to-pediatric-patients
FDA Expands Johnson & Johnson Ulcerative C...
10/08/2025 16:57:07

FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive...

reported-earlier-johnson--johnson-receives-fda-approval-for-simponi-to-treat-moderately-to-severely-active-pediatric-ulcerative-colitis
Reported Earlier, Johnson & Johnson Receiv...
10/08/2025 07:34:35

Approval expands SIMPONI® indication to treat children weighing at least 15 kg with moderately to severely active ulcerative co...

congresswoman-violates-stock-act-with-late-trade-disclosures-purchases-include-bitcoin-etf
Congresswoman Violates STOCK Act With Late...
10/07/2025 22:03:59

As legislation in Congress heats up to ban elected officials from buying and selling stocks, several members have violated the ...

Core News & Articles
Legend Biotech Says Legend Biotech USA Ent...
10/07/2025 20:15:04

Legend Biotech USA Inc. Enters into Component and Product Supply Agreement with Janssen Pharmaceuticals, Inc.On October 6, 2025...

citigroup-maintains-buy-on-johnson--johnson-raises-price-target-to-213
Citigroup Maintains Buy on Johnson & Johns...
10/07/2025 17:44:47

Citigroup analyst Joanne Wuensch maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $200...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION